BioSpace News Archive

Drug Development

CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study of rVIII-SingleChain (Recombinant Single-Chain Factor VIII) for Treatment of Hemophilia A

June 4, 2013
·
5 min read
Business

Bruker Corporation and 3M Company Sign Exclusive Patent License Agreement

June 4, 2013
·
3 min read
Pharm Country

BrainStorm Cell Therapeutics Inc. Receives 1.2 Million NIS Grant From Israel’s Office of the Chief Scientist

June 4, 2013
·
3 min read
Business

Judy Murrah Joins Applied DNA Sciences, Inc. as Chief Information Officer

June 4, 2013
·
3 min read
Drug Development

PhaseBio Pharmaceuticals, Inc. Initiated Phase 1 Study of Investigational Once-Weekly Basal Insulin for Potential Treatment of Diabetes

June 4, 2013
·
1 min read
Bio NC

Quintiles, Inc. Receives Award From Patient-Centered Outcomes Research Institute to Compare the Effectiveness of Uterine Fibroid Treatments in Real-World Practice

June 4, 2013
·
1 min read
Pharm Country

Advaxis, Inc. Announces Amendment of Proxy Statement Supplement Further Reduction in Share Capital Proposal

June 4, 2013
·
1 min read
Biotech Bay

BioTime to Raise $9 Million in Registered Direct Offering

June 4, 2013
·
1 min read
Vycor Medical Inc.'S NovaVision® Unit Awarded Its 30th Patent

June 4, 2013
·
7 min read
Drug Development

Merrimack Pharmaceuticals Inc.’ Phase 1 Research Supports MM-121 Potential for Investigation as Combination With Chemotherapy in Patients With Advanced Solid Tumors

June 4, 2013
·
5 min read